Natarajan MK - Search Results

1

Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) study.

Madan M, Nikhil J, Hellkamp AS, Pieper KS, Labinaz M, Cohen EA, Buller CE, Cantor WJ, Seidelin P, Ducas J, Carere RG, Natarajan MK, O'Shea JC, Tcheng JE; ESPRIT Investigators. Madan M, et al. Among authors: natarajan mk. Can J Cardiol. 2009 Aug;25(8):e269-72. doi: 10.1016/s0828-282x(09)70120-5. Can J Cardiol. 2009. PMID: 19668787 Free PMC article.

2

Early and late quantitative angiographic results of vein graft lesions treated by excimer laser with adjunctive balloon angioplasty.

Strauss BH, Natarajan MK, Batchelor WB, Yardley DE, Bittl JA, Sanborn TA, Power JA, Watson LE, Moothart R, Tcheng JE, et al. Strauss BH, et al. Among authors: natarajan mk. Circulation. 1995 Aug 1;92(3):348-56. doi: 10.1161/01.cir.92.3.348. Circulation. 1995. PMID: 7634448 Clinical Trial.

3

Failed coronary stent deployment.

Cantor WJ, Lazzam C, Cohen EA, Bowman KA, Dolman S, Mackie K, Natarajan MK, Strauss BH. Cantor WJ, et al. Among authors: natarajan mk. Am Heart J. 1998 Dec;136(6):1088-95. doi: 10.1016/s0002-8703(98)70168-1. Am Heart J. 1998. PMID: 9842025

4

Evaluation of the role of abciximab (Reopro) as a rescue agent during percutaneous coronary interventions: in-hospital and six-month outcomes.

Velianou JL, Strauss BH, Kreatsoulas C, Pericak D, Natarajan MK. Velianou JL, et al. Among authors: natarajan mk. Catheter Cardiovasc Interv. 2000 Oct;51(2):138-44. doi: 10.1002/1522-726x(200010)51:2<138::aid-ccd2>3.0.co;2-u. Catheter Cardiovasc Interv. 2000. PMID: 11025564 Clinical Trial.

5

Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction.

Jong P, Cohen EA, Batchelor W, Lazzam C, Kreatsoulas C, Natarajan MK, Strauss BH. Jong P, et al. Among authors: natarajan mk. Am Heart J. 2001 Feb;141(2):218-25. doi: 10.1067/mhj.2001.112239. Am Heart J. 2001. PMID: 11174335

6

Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions.

Natarajan MK, Kreatsoulas C, Velianou JL, Mehta SR, Pericak D, Goodhart DM. Natarajan MK, et al. Am J Cardiol. 2004 Mar 15;93(6):750-3. doi: 10.1016/j.amjcard.2003.11.069. Am J Cardiol. 2004. PMID: 15019884

7

Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.

Segev A, Kassam S, Buller CE, Lau HK, Sparkes JD, Connelly PW, Seidelin PH, Natarajan MK, Cohen EA, Strauss BH. Segev A, et al. Among authors: natarajan mk. Eur Heart J. 2004 Jun;25(12):1029-35. doi: 10.1016/j.ehj.2004.04.027. Eur Heart J. 2004. PMID: 15191773

8

Low rates of angiographic and clinical restenosis with the new flexible MedStent for the treatment of single discrete coronary lesions.

Segev A, Cantor WJ, Cohen EA, Seidelin PH, Natarajan MK, Marquis JF, Lazzam C, Watson RK, Chisholm RJ, Strauss BH. Segev A, et al. Among authors: natarajan mk. J Interv Cardiol. 2004 Jun;17(3):167-70. doi: 10.1111/j.1540-8183.2004.09881.x. J Interv Cardiol. 2004. PMID: 15209579 Clinical Trial.

9

A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting.

Madan M, Labinaz M, Cohen EA, Buller CE, Cantor WJ, Seidelin P, Ducas J, Carere RG, Natarajan MK, Pieper KS, Hafley GE, O'Shea JC, Kitt MM, Califf RM, Tcheng JE; ESPRIT Investigators. Madan M, et al. Among authors: natarajan mk. Can J Cardiol. 2004 Nov;20(13):1343-9. Can J Cardiol. 2004. PMID: 15570357 Clinical Trial.

10

Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial.

Mehta SR, Steg PG, Granger CB, Bassand JP, Faxon DP, Weitz JI, Afzal R, Rush B, Peters RJ, Natarajan MK, Velianou JL, Goodhart DM, Labinaz M, Tanguay JF, Fox KA, Yusuf S; ASPIRE Investigators. Mehta SR, et al. Among authors: natarajan mk. Circulation. 2005 Mar 22;111(11):1390-7. doi: 10.1161/01.CIR.0000158485.70761.67. Circulation. 2005. PMID: 15781750 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page